UBS Group AG - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 19 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$10100
-98.2%
0.00%
Q3 2022$0
-100.0%
5,606
+94.1%
0.00%
Q4 2021$5,0002,8880.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
LMR Partners LLP 358,349$520,0000.01%
Shaolin Capital Management LLC 823,999$156,0000.00%
Yakira Capital Management, Inc. 108,485$17,0000.00%
Radcliffe Capital Management, L.P. 55,692$81,0000.00%
EQUITEC PROPRIETARY MARKETS, LLC 45,000$7,0000.00%
MARSHALL WACE, LLP 285,000$413,0000.00%
MORGAN STANLEY 148,939$22,0000.00%
Walleye Trading LLC 15,505$2,0000.00%
Citadel Advisors 18,711$3,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,944$2,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders